OCUL
Ocular Therapeutix Inc
9.70$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +37.8% | +16.8% | +84.4% | +40.7% | +10.7% | +9.6% | -12.7% | -12.9% | +41.4% | +26.9% | +14.2% | |
| – | +75.5% | +28.4% | +22.9% | +2.2% | +17.1% | -14.0% | +98.9% | +13.3% | +5.1% | +85.7% | +30.4% | |
| – | +62.6% | +67.2% | +1.7% | +2.3% | -40.5% | +2,003.2% | -162.4% | – | – | – | – | |
| – | -76.7% | +312.7% | +71.0% | -83.5% | -420.5% | – | -346.9% | – | -649.4% | – | – | |
| – | +41.1% | +7.9% | +330.0% | -77.1% | +18.5% | -62.4% | +42.0% | +211.1% | +63.8% | -78.8% | +832.5% | |
| – | 0.0% | – | -23.9% | -107.0% | +18.5% | -62.4% | +42.0% | +211.1% | +63.8% | -78.8% | +822.4% | |
| – | -85.9% | -100.0% | – | -93.2% | +12,450.5% | -98.0% | -5.0% | – | – | – | – | |
| – | +289.1% | +343.4% | -75.0% | +7.6% | +51.9% | +65.6% | +31.9% | -4.6% | -9.5% | +19.4% | +56.7% | |
| – | -96.8% | +504.5% | +0.0% | +165.6% | +484.7% | -101.2% | +0.0% | -100.0% | – | -100.0% | – | |
| – | -16.8% | -99.1% | +5,371.5% | +114.4% | +9.8% | +202.6% | -98.7% | -49.0% | +11,580.1% | +95.6% | +69.1% | |
| – | -133.2% | – | +299.7% | +103.7% | -125.5% | – | -136.8% | – | – | +109.8% | +75.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.